Product
Cytarabine liposome
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Randomized, Open-label, Two-period, Two-way Crossover Bioequivalence Study of Two (Cytarabine: Daunorubicin) Liposome for Injection in Elderly AML SubjectsStatus: Recruiting, Estimated PCD: 2025-04-01